Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The evaluation of genetic tests.
Zimmern RL, Kroese M. Zimmern RL, et al. Among authors: kroese m. J Public Health (Oxf). 2007 Sep;29(3):246-50. doi: 10.1093/pubmed/fdm028. Epub 2007 May 24. J Public Health (Oxf). 2007. PMID: 17526507 Review.
Defining purpose: a key step in genetic test evaluation.
Burke W, Zimmern RL, Kroese M. Burke W, et al. Among authors: kroese m. Genet Med. 2007 Oct;9(10):675-81. doi: 10.1097/gim.0b013e318156e45b. Genet Med. 2007. PMID: 18073580 No abstract available.
Array-based comparative genomic hybridization for investigating chromosomal abnormalities in patients with learning disability: systematic review meta-analysis of diagnostic and false-positive yields.
Subramonia-Iyer S, Sanderson S, Sagoo G, Higgins J, Burton H, Zimmern R, Kroese M, Brice P, Shaw-Smith C. Subramonia-Iyer S, et al. Among authors: kroese m. Genet Med. 2007 Feb;9(2):74-9. doi: 10.1097/gim.0b013e31803141f2. Genet Med. 2007. PMID: 17304048
How can genetic tests be evaluated for clinical use? Experience of the UK Genetic Testing Network.
Kroese M, Zimmern RL, Farndon P, Stewart F, Whittaker J. Kroese M, et al. Eur J Hum Genet. 2007 Sep;15(9):917-21. doi: 10.1038/sj.ejhg.5201867. Epub 2007 May 30. Eur J Hum Genet. 2007. PMID: 17534375
How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom.
Sanderson S, Zimmern R, Kroese M, Higgins J, Patch C, Emery J. Sanderson S, et al. Among authors: kroese m. Genet Med. 2005 Sep;7(7):495-500. doi: 10.1097/01.gim.0000179941.44494.73. Genet Med. 2005. PMID: 16170241
Genetic tests and their evaluation: can we answer the key questions?
Kroese M, Zimmern RL, Sanderson S. Kroese M, et al. Genet Med. 2004 Nov-Dec;6(6):475-80. doi: 10.1097/01.gim.0000144060.84960.36. Genet Med. 2004. PMID: 15545742 Review.
HER2 status in breast cancer--an example of pharmacogenetic testing.
Kroese M, Zimmern RL, Pinder SE. Kroese M, et al. J R Soc Med. 2007 Jul;100(7):326-9. doi: 10.1177/014107680710000715. J R Soc Med. 2007. PMID: 17606754 Free PMC article. Review.
Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented at accountability for reasonableness.
Severin F, Borry P, Cornel MC, Daniels N, Fellmann F, Victoria Hodgson S, Howard HC, John J, Kääriäinen H, Kayserili H, Kent A, Koerber F, Kristoffersson U, Kroese M, Lewis C, Marckmann G, Meyer P, Pfeufer A, Schmidtke J, Skirton H, Tranebjærg L, Rogowski WH; EuroGentest and ESHG/PPPC Priority Consortium. Severin F, et al. Among authors: kroese m. Eur J Hum Genet. 2015 Jun;23(6):729-35. doi: 10.1038/ejhg.2014.190. Epub 2014 Sep 24. Eur J Hum Genet. 2015. PMID: 25248395 Free PMC article.
Evaluation of genetic tests for susceptibility to common complex diseases: why, when and how?
Wright CF, Kroese M. Wright CF, et al. Among authors: kroese m. Hum Genet. 2010 Feb;127(2):125-34. doi: 10.1007/s00439-009-0767-x. Epub 2009 Nov 20. Hum Genet. 2010. PMID: 19936793
A framework for the prioritization of investment in the provision of genetic tests.
Kroese M, Burton H, Whittaker J, Lakshman R, Alberg C. Kroese M, et al. Public Health Genomics. 2010;13(7-8):538-43. doi: 10.1159/000294278. Epub 2010 Mar 15. Public Health Genomics. 2010. PMID: 20224243
65 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page